Front Row Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-170
| Closed | -$35.1K | – | 585 |
|
|
2024
Q2 | $35.1K | Sell |
170
-2
| -1% | -$413 | 0.01% | 312 |
|
|
2024
Q1 | $46.6K | Buy |
+172
| New | +$46.6K | 0.02% | 270 |
|
|
2023
Q4 | – | Sell |
-178
| Closed | -$34.9K | – | 554 |
|
|
2023
Q3 | $34.9K | Buy |
178
+1
| +0.6% | +$196 | 0.02% | 278 |
|
|
2023
Q2 | $37K | Sell |
177
-5
| -3% | -$1.05K | 0.02% | 275 |
|
|
2023
Q1 | $37K | Sell |
182
-2
| -1% | -$407 | 0.02% | 273 |
|
|
2022
Q4 | $40K | Hold |
184
| – | – | 0.02% | 261 |
|
|
2022
Q3 | $36K | Sell |
184
-1
| -0.5% | -$196 | 0.02% | 271 |
|
|
2022
Q2 | $40K | Hold |
185
| – | – | 0.02% | 267 |
|
|
2022
Q1 | $53K | Sell |
185
-1
| -0.5% | -$286 | 0.02% | 256 |
|
|
2021
Q4 | $70K | Sell |
186
-23
| -11% | -$8.66K | 0.03% | 232 |
|
|
2021
Q3 | $86K | Hold |
209
| – | – | 0.04% | 212 |
|
|
2021
Q2 | $88K | Sell |
209
-44
| -17% | -$18.5K | 0.04% | 209 |
|
|
2021
Q1 | $73K | Sell |
253
-5
| -2% | -$1.44K | 0.04% | 213 |
|
|
2020
Q4 | $64K | Hold |
258
| – | – | 0.03% | 225 |
|
|
2020
Q3 | $59K | Sell |
258
-2
| -0.8% | -$457 | 0.03% | 229 |
|
|
2020
Q2 | $45K | Buy |
260
+47
| +22% | +$8.14K | 0.03% | 231 |
|
|
2020
Q1 | $31K | Hold |
213
| – | – | 0.02% | 268 |
|
|
2019
Q4 | $33K | Hold |
213
| – | – | 0.02% | 247 |
|
|
2019
Q3 | $28K | Hold |
213
| – | – | 0.02% | 258 |
|
|
2019
Q2 | $30K | Hold |
213
| – | – | 0.02% | 258 |
|
|
2019
Q1 | $31K | Sell |
213
-2
| -0.9% | -$291 | 0.02% | 246 |
|
|
2018
Q4 | $24K | Hold |
215
| – | – | 0.02% | 261 |
|
|
2018
Q3 | $24 | Sell |
215
-44
| -17% | -$5 | 0.02% | 279 |
|
|
2018
Q2 | $32 | Hold |
259
| – | – | 0.02% | 269 |
|
|
2018
Q1 | $28K | Sell |
259
-6
| -2% | -$649 | 0.02% | 286 |
|
|
2017
Q4 | $29K | Buy |
+265
| New | +$29K | 0.02% | 291 |
|